Literature DB >> 19949849

Blood pressure and risk of prostate cancer: Cohort Norway (CONOR).

Richard M Martin1, Lars Vatten, David Gunnell, Pål Romundstad.   

Abstract

BACKGROUND: Some studies suggest that raised blood pressure may increase prostate cancer risk. We investigated associations of blood pressure with prostate cancer within the CONOR collaborative cohorts of Norway.
METHODS: Between 1994 and 2003, 82,098 men from ten population-based cohorts in Norway completed standardised questionnaires and physical examinations, including resting blood pressure. The unique 11-digit identification number of Norwegian citizens allowed linkage with the Cancer Registry of Norway.
RESULTS: A total of 78,768 (96%) men who were cancer-free at baseline and average age of 50.3 years (standard deviation, SD: 15.2) were followed up for a mean of 9.15 years. 11.4% of these men used antihypertensive drugs at baseline. During follow-up (1994-2006), 1,974 incident prostate cancers were diagnosed. We found a 4% (95% confidence interval, CI = 0-9%) increased risk of prostate cancer per one SD (18.3 mmHg) increase in systolic blood pressure and similar findings for diastolic blood pressure (hazard ratio, HR: 1.05 per SD; 95% CI = 1.01-1.10). The association was stronger for advanced (HR: 1.16 per SD increase in systolic blood pressure; 95% CI = 1.05-1.27) compared with localised (1.01; 0.95-1.08) prostate cancer (p for heterogeneity in hazard ratios = 0.02).
CONCLUSIONS: Raised blood pressure was associated with an increased risk of prostate cancer, particularly advanced cancers at diagnosis. Understanding the mechanisms underlying these findings may provide biological insights into prostate carcinogenesis. Even if the association was causal, our data suggest that raised blood pressure would account for only 3% of prostate cancers, so the public health impact of this association may be limited.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19949849     DOI: 10.1007/s10552-009-9477-x

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  12 in total

1.  Blood pressure and risk of cancer in the European Prospective Investigation into Cancer and Nutrition.

Authors:  Sofia Christakoudi; Artemisia Kakourou; Georgios Markozannes; Ioanna Tzoulaki; Elisabete Weiderpass; Paul Brennan; Marc Gunter; Christina C Dahm; Kim Overvad; Anja Olsen; Anne Tjønneland; Marie-Christine Boutron-Ruault; Anne-Laure Madika; Gianluca Severi; Verena Katzke; Tilman Kühn; Manuela M Bergmann; Heiner Boeing; Anna Karakatsani; Georgia Martimianaki; Paschalis Thriskos; Giovanna Masala; Sabina Sieri; Salvatore Panico; Rosario Tumino; Fulvio Ricceri; Antonio Agudo; Daniel Redondo-Sánchez; Sandra M Colorado-Yohar; Olatz Mokoroa; Olle Melander; Tanja Stocks; Christel Häggström; Sophia Harlid; Bas Bueno-de-Mesquita; Carla H van Gils; Roel C H Vermeulen; Kay-Tee Khaw; Nicholas J Wareham; Tammy Y N Tong; Heinz Freisling; Mattias Johansson; Hannah Lennon; Dagfinn Aune; Elio Riboli; Dimitrios Trichopoulos; Antonia Trichopoulou; Konstantinos K Tsilidis
Journal:  Int J Cancer       Date:  2019-08-20       Impact factor: 7.396

2.  Midlife metabolic factors and prostate cancer risk in later life.

Authors:  Barbra A Dickerman; Johanna E Torfadottir; Unnur A Valdimarsdottir; Kathryn M Wilson; Laufey Steingrimsdottir; Thor Aspelund; Julie L Batista; Katja Fall; Edward Giovannucci; Lara G Sigurdardottir; Laufey Tryggvadottir; Vilmundur Gudnason; Sarah C Markt; Lorelei A Mucci
Journal:  Int J Cancer       Date:  2017-11-16       Impact factor: 7.396

3.  The association between calcium channel blocker use and prostate cancer outcome.

Authors:  Michael A Poch; Diana Mehedint; Dawn J Green; Rochelle Payne-Ondracek; Elizabeth T H Fontham; Jeannette T Bensen; Kristopher Attwood; Gregory E Wilding; Khurshid A Guru; Willie Underwood; James L Mohler; Hannelore V Heemers
Journal:  Prostate       Date:  2012-12-31       Impact factor: 4.104

Review 4.  The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence.

Authors:  Yu-zhu Xiang; Hui Xiong; Zi-lian Cui; Shao-bo Jiang; Qing-hua Xia; Yong Zhao; Guan-bin Li; Xun-bo Jin
Journal:  J Exp Clin Cancer Res       Date:  2013-02-13

5.  Risk factors for prostate cancer: An hospital-based case-control study from Mumbai, India.

Authors:  B Ganesh; Sushama L Saoba; Monika N Sarade; Suvarna V Pinjari
Journal:  Indian J Urol       Date:  2011-07

6.  Oxidative DNA damage in kidneys and heart of hypertensive mice is prevented by blocking angiotensin II and aldosterone receptors.

Authors:  Susanne Brand; Kerstin Amann; Philipp Mandel; Anna Zimnol; Nicole Schupp
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

7.  The risk of cancer in patients with generalized anxiety disorder: a nationwide population-based study.

Authors:  Cheng-Che Shen; Yu-Wen Hu; Li-Yu Hu; Man-Hsin Hung; Tung-Ping Su; Min-Wei Huang; Chia-Fen Tsai; Shuo-Ming Ou; Sang-Hue Yen; Cheng-Hwai Tzeng; Tzeon-Jye Chiou; Tzeng-Ji Chen; Chia-Jen Liu
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

8.  Comorbidities and Concomitant Medication Use in Men with Prostate Cancer or High Levels of PSA Compared to Matched Controls: A GPRD Analysis.

Authors:  Haojie Li; Elizabeth Hodgson; Louise Watson; Amit Shukla; Jeanenne J Nelson
Journal:  J Cancer Epidemiol       Date:  2012-04-11

9.  The Prevalence of Cardiac Risk Factors in Men with Localized Prostate Cancer Undergoing Androgen Deprivation Therapy in British Columbia, Canada.

Authors:  Margot K Davis; Jennifer L Rajala; Scott Tyldesley; Tom Pickles; Sean A Virani
Journal:  J Oncol       Date:  2015-08-02       Impact factor: 4.375

10.  Asthma and Risk of Prostate Cancer: A Population-Based Case-Cohort Study in Taiwan.

Authors:  Yu-Li Su; Ching-Lan Chou; Kun-Ming Rau; Charles Tzu-Chi Lee
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.